NO175640C - Fusion proteins and DNA encoding them - Google Patents

Fusion proteins and DNA encoding them

Info

Publication number
NO175640C
NO175640C NO863000A NO863000A NO175640C NO 175640 C NO175640 C NO 175640C NO 863000 A NO863000 A NO 863000A NO 863000 A NO863000 A NO 863000A NO 175640 C NO175640 C NO 175640C
Authority
NO
Norway
Prior art keywords
sequence
amino acids
genetically codable
genetically
fusion protein
Prior art date
Application number
NO863000A
Other languages
Norwegian (no)
Other versions
NO863000L (en
NO175640B (en
NO863000D0 (en
Inventor
Paul Habermann
Siegfried Stengelin
Friedrich Wengenmayer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO863000D0 publication Critical patent/NO863000D0/en
Publication of NO863000L publication Critical patent/NO863000L/en
Publication of NO175640B publication Critical patent/NO175640B/no
Publication of NO175640C publication Critical patent/NO175640C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A fusion protein of the general formula Met - Xn - D' - Y - Z in which n is zero or 1, X is a sequence of 1 to 12 genetically codable amino acids, D' is a sequence of about 70 amino acids in the region of the sequence of amino acids 23 - 93 of the D-peptide in the trp operon of E. coli, Y denotes a sequence of one or more genetically codable amino acids which permits the following amino acid sequence Z to be cleaved off, and Z is a sequence of genetically codable amino acids. 1. Claims for the Contracting State : AT A process for the preparation of a fusion protein of the general formula (1) Met - Xn - D' - Y - Z in which n is zero or 1, X is a sequence of 1 to 12 genetically codable amino acids, D' is a sequence of about 70 amino acids in the region of the sequence of amino acids 23 - 93 of the D-peptide in the trp operon of E. coli, Y denotes a sequence of one or more genetically codable amino acids which permits the following amino acid sequence Z to be cleaved off, and Z is a sequence of genetically codable amino acids, characterized by expressing a gene structure which codes for these fusion proteins in a host cell, and separating the fusion protein.
NO863000A 1985-07-27 1986-07-25 Fusion proteins and DNA encoding them NO175640C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853526995 DE3526995A1 (en) 1985-07-27 1985-07-27 FUSION PROTEINS, METHOD FOR THEIR PRODUCTION AND THEIR USE

Publications (4)

Publication Number Publication Date
NO863000D0 NO863000D0 (en) 1986-07-25
NO863000L NO863000L (en) 1987-01-28
NO175640B NO175640B (en) 1994-08-01
NO175640C true NO175640C (en) 1994-11-09

Family

ID=6276985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863000A NO175640C (en) 1985-07-27 1986-07-25 Fusion proteins and DNA encoding them

Country Status (18)

Country Link
EP (1) EP0211299B1 (en)
JP (1) JPH07113040B2 (en)
KR (1) KR950000299B1 (en)
AT (1) ATE50596T1 (en)
AU (1) AU595221B2 (en)
CA (1) CA1336329C (en)
DE (2) DE3526995A1 (en)
DK (1) DK172618B1 (en)
ES (1) ES2000278A6 (en)
FI (1) FI86887C (en)
GR (1) GR861957B (en)
HU (1) HU197356B (en)
IE (1) IE59127B1 (en)
IL (1) IL79522A (en)
NO (1) NO175640C (en)
NZ (1) NZ216967A (en)
PT (1) PT83065B (en)
ZA (1) ZA865556B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738541A1 (en) * 1987-11-13 1989-05-24 Hoechst Ag METHOD FOR INSULATING AND CLEANING HIRUDINE
DE3541856A1 (en) * 1985-11-27 1987-06-04 Hoechst Ag EUKARYOTIC FUSION PROTEINS, THEIR PRODUCTION AND USE, AND MEANS FOR CARRYING OUT THE PROCESS
DE3781819T2 (en) * 1986-03-12 1993-01-07 Imcera Group Inc HYBRID EXPRESSION VECTORS, THEIR PRODUCTION AND USE.
AU1987088A (en) * 1987-06-24 1989-01-19 Novo Nordisk A/S A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
US5358857A (en) * 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
DE3942580A1 (en) * 1989-12-22 1991-06-27 Basf Ag METHOD FOR PRODUCING HIRUDINE
ES2218622T3 (en) 1996-07-26 2004-11-16 Aventis Pharma Deutschland Gmbh INSULIN DERIVATIVES WITH INCREASED ZINC UNION ACTIVITY.
DE19726167B4 (en) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, process for its preparation and pharmaceutical preparation containing it
DE19825447A1 (en) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh New insulin analogues with increased zinc formation
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
DE10227232A1 (en) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Sour insulin preparations with improved stability
DK2201120T3 (en) 2007-09-21 2014-03-17 Cadila Healthcare Ltd GCSF fusion protein systems which are suitable for high expression of the peptides
SI3228320T1 (en) 2008-10-17 2020-03-31 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a glp-1 agonist
TR201809460T4 (en) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Pharmaceutical composition comprising a GLP-1-agonist, an insulin and methionine.
JP5973918B2 (en) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Pharmaceutical composition comprising a GLP-1 agonist and methionine
RU2546520C2 (en) 2010-08-30 2015-04-10 Санофи-Авентис Дойчланд Гмбх Application of ave0010 for production of medication for treatment of type 2 diabetes mellitus
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
KR101983982B1 (en) 2011-08-29 2019-05-30 사노피-아벤티스 도이칠란트 게엠베하 Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
AR087744A1 (en) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
MA41138B1 (en) 2014-12-12 2023-07-31 Sanofi Aventis Deutschland INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients
KR20200080747A (en) 2018-12-27 2020-07-07 주식회사 폴루스 An Enzymatic Conversion Composition for Producing Insulin from Proinsulin and a Method for Producing Insulin from Proinsulin Using the Same
KR20200080748A (en) 2018-12-27 2020-07-07 주식회사 폴루스 A Method for Purifying Proinsulin Using Anion Exchange Chromatography

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68404B (en) * 1979-06-01 1981-12-29 Univ California
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
WO1986005513A1 (en) * 1985-03-18 1986-09-25 Gene Labs, Inc. Hybrid-gene cassette vector
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
ES8706824A1 (en) * 1985-04-08 1987-07-01 Genetic Systems Corp EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV.

Also Published As

Publication number Publication date
ZA865556B (en) 1987-03-25
KR870001312A (en) 1987-03-13
NO863000L (en) 1987-01-28
IL79522A0 (en) 1986-10-31
CA1336329C (en) 1995-07-18
IL79522A (en) 1991-08-16
KR950000299B1 (en) 1995-01-13
DK355486A (en) 1987-01-28
HUT43629A (en) 1987-11-30
EP0211299A3 (en) 1988-06-01
DE3526995A1 (en) 1987-02-05
AU6056586A (en) 1987-01-29
IE59127B1 (en) 1994-01-12
NZ216967A (en) 1988-08-30
HU197356B (en) 1989-03-28
FI86887C (en) 1992-10-26
PT83065B (en) 1989-02-28
NO175640B (en) 1994-08-01
GR861957B (en) 1986-11-25
ATE50596T1 (en) 1990-03-15
FI863041A0 (en) 1986-07-24
IE861977L (en) 1987-01-27
JPH07113040B2 (en) 1995-12-06
FI86887B (en) 1992-07-15
DE3669175D1 (en) 1990-04-05
DK355486D0 (en) 1986-07-25
PT83065A (en) 1986-08-01
DK172618B1 (en) 1999-03-01
EP0211299A2 (en) 1987-02-25
JPS6229600A (en) 1987-02-07
ES2000278A6 (en) 1988-02-01
NO863000D0 (en) 1986-07-25
EP0211299B1 (en) 1990-02-28
AU595221B2 (en) 1990-03-29
FI863041A (en) 1987-01-28

Similar Documents

Publication Publication Date Title
NO175640C (en) Fusion proteins and DNA encoding them
EP0722461A4 (en) Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
FI880017A0 (en) Method for preparing pancreatic trypsin inhibitor variants and DNA, vector and host cell used in the method
DE3650540D1 (en) Antigenic proteins and vaccines containing them to prevent coccidiosis
ATE91722T1 (en) EQUINE GAMMA INTERFERON.
FI865003A0 (en) Process for the preparation of thrombin inhibitors
AU2795989A (en) Production of gonorrheal pi proteins and vaccines
ATE89317T1 (en) PROTEINS, EXPRESSION VECTORS CONTAINING DNA ENCODING FOR SUCH PROTEINS, AND CELLS CONTAINING SUCH EXPRESSION VECTORS.
ATE46188T1 (en) POSITION SPECIFIC PROTEOLYSIS USING RENIN.
SE8601940D0 (en) PREPARATION OF FUSED PROTEINS, ANTIBODIES AND PROCESSES THEREFOR
DK0805204T3 (en) Biticle - specifically receptor protein and its use
DE3650477D1 (en) Production of active proteins containing cystine residues
ATE136057T1 (en) AUTONOMOUSLY REPLICATING DNA FRAGMENTS FROM MAMMAL CELLS WITH AFFINITY FOR DNA-BINDING PROTEINS
DK27097A (en) Minactivin and its method of preparation
FI934079A (en) Method for preparing a fusion protein